NCT05023226

Brief Summary

The study was designed to comparison the effectiveness of recruitment maneuvers(RM) and lung protective ventilation strategy(LPVS) for patients with moderate to severe ARDS. ARDS patients were randomly divided into two groups, the experimental group (LPVS+RM group) and the control group (LPVS group). The method of RM refers to that under FiO2=100% oxygen concentration and fixed inspiratory pressure (15cmH2O), the PEEP starts from 10 cmH2O and increases at a pressure of 5 cmH2O every minute until the Peak inspiratory Pressure(PIP) reaches 55cmH2O, and the arterial blood oxygen is monitored at the same time. The pressure point when the partial pressure of arterial oxygen PaO2+PaCO2≧400mmHg is the best PEEP. The primary endpoint indicators were oxygenation index(OI) and lung ultrasound score(LUS) from day 1 to day 7. The secondary outcome indicators were the ventilator days, length of stay in the ICU (days), and ICU mortality.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 26, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

October 5, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
Last Updated

February 1, 2023

Status Verified

January 1, 2023

Enrollment Period

1.9 years

First QC Date

August 21, 2021

Last Update Submit

January 30, 2023

Conditions

Keywords

Acute respiratory distress syndrome (ARDS)Recruitment maneuvers (RM)Oxygenation index(OI)Lung ultrasound score(LUS)

Outcome Measures

Primary Outcomes (2)

  • Oxygenation index(OI)

    Difference in OI between baseline and 72 hrs after enrollment 【The oxygenation index assesses the intensity of ventilatory support that is needed to maintain adequate oxygenation. The formula is: Oxygenation index = (FiO2 x PAW) / PaO2. The lower the OI(\<25) the better the outcome】

    Baseline - 72 hrs after enrollment

  • Lung ultrasound score(LUS)

    Difference in LUS between baseline and 72 hrs after enrollment 【LUS is a score that measures lung aeration, score ranging from 0 to 36 points, the higher the score is mean the worse the ventilation of the lungs】

    Baseline - 72 hrs after enrollment

Secondary Outcomes (3)

  • Ventilator days

    Removal of endotracheal tube day - Insertion endotracheal tube day + 1 day

  • Length of stay in the ICU (days)

    Transfer out of ICU day - Admission to ICU day + 1 day

  • ICU mortality

    During ICU course

Study Arms (2)

LPVS group

PLACEBO COMPARATOR

The general ventilator setting.

Procedure: LPVS

LPVS + RM group

EXPERIMENTAL

Recruitment maneuver.

Procedure: RMProcedure: LPVS

Interventions

RMPROCEDURE

RM refers to that under FiO2=100% oxygen concentration and fixed inspiratory pressure (15cmH2O), the PEEP starts from 10 cmH2O and increases at a pressure of 5 cmH2O every minute until the Peak inspiratory Pressure(PIP) reaches 55cmH2O, and the level was fixed to 40 seconds in each increment. Then, the ventilator was transferred to PEEP-titration phase, the PEEP was adjusted to 25 cm H2O, and it was reduced by increments of 5 cm H2O each time. The each increment was fixed to 5 minutes till the end-maneuver PEEP.

Also known as: Recruitment maneuver
LPVS + RM group
LPVSPROCEDURE

LPVS was used by the pressure-controlled mode and the PEEP was titrated by the level of FiO2 to keep the saturation of oxygen (SaO2) more than 90%. The level of pressure control was adjusted to maintain low tidal volume (6-8 mL/kg predicted body weight \[PBW\]) strategy. The respiratory rate and tidal volume were setting to avoid unstable hemodynamic data and adjusted by blood gas data and lung mechanics.

Also known as: Lung protective ventilation strategies
LPVS + RM groupLPVS group

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 20 to 70 years old.
  • Patients with hypoxemia receiving endotracheal mechanical ventilation therapy.
  • The ARDS diagnostic criteria of Berlin Definition, arterial oxygen tension \[PaO2\]/fractional inspired oxygen \[FiO2\] ratio (PaO2/FiO2) \<200 mm Hg, recent appearance of bilateral pulmonary infiltrates consistent with edema and no clinical evidence of left atrial hypertension.
  • Within 72 hours after ARDS diagnosis.

You may not qualify if:

  • Pregnancy.
  • Participate in other interventional trials at the same time during the acceptance period.
  • Severe trauma combined with rib fracture or pneumothorax, subcutaneous emphysema, and mediastinal air accumulation within three months.
  • Severe chronic respiratory diseases that require long-term use of oxygen therapy or home mechanical ventilation.
  • Have a history of cachexia or terminal cancer.
  • Use immunosuppressants, chemotherapy or radiation therapy.
  • Contraindications for hypercapnia, such as patients with acute brain injury due to intracranial hypertension or craniotomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asia University

Taichung, Wufeng, 41354, Taiwan

RECRUITING

Related Publications (1)

  • Chung FT, Lee CS, Lin SM, Kuo CH, Wang TY, Fang YF, Hsieh MH, Chen HC, Lin HC. Alveolar recruitment maneuver attenuates extravascular lung water in acute respiratory distress syndrome. Medicine (Baltimore). 2017 Jul;96(30):e7627. doi: 10.1097/MD.0000000000007627.

Related Links

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Zi-Tin Kuan, RN

    Asia University Hospital

    STUDY DIRECTOR

Central Study Contacts

Zi-Tin Kuan, RN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 21, 2021

First Posted

August 26, 2021

Study Start

October 5, 2021

Primary Completion

August 31, 2023

Study Completion

August 31, 2023

Last Updated

February 1, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations